Counterfeit bulk drugs : (Registro nro. 271008)

Detalles MARC
000 -LEADER
fixed length control field 01932nam a2200373Ia 4500
001 - CONTROL NUMBER
control field ocm47755624
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20180511125017.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field he bmb024bbca
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 010810s2000 dcua b f000 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency FPS
Language of cataloging eng
Transcribing agency FPS
Modifying agency OCLCQ
-- OCLCF
-- OCLCO
-- OCLCQ
-- OCLCO
-- OCLCQ
-- GPO
-- MvI
043 ## -
Geographic area code n-us---
074 ## -
GPO item number 1019-B-01 (MF)
086 0# -
Classification number Y 4.C 73/8:106-164
099 ## -
Classification number Y 4.C 73/8:106-164
110 1# - MAIN ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element United States.
Subordinate unit Congress.
-- House.
-- Committee on Commerce.
-- Subcommittee on Oversight and Investigations.
245 10 - TITLE STATEMENT
Title Counterfeit bulk drugs :
Remainder of title hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Sixth Congress, second session, June 8 and October 3, 2000.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Washington :
Name of publisher, distributor, etc. U.S. G.P.O. :
-- For sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O.,
Date of publication, distribution, etc. 2000.
300 ## - PHYSICAL DESCRIPTION
Extent iii, 423 pages :
Other physical details illustrations ;
Dimensions 24 cm
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term microform
Media type code h
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term microfiche
Carrier type code he
Source rdacarrier
500 ## - GENERAL NOTE
General note "Serial no. 106-164."
General note Shipping list no not available.
General note CRDP Program record.
533 ## -
Type of reproduction Microfiche.
Place of reproduction Washington :
Agency responsible for reproduction U.S. G.P.O.,
Date of reproduction 2001.
Physical description of reproduction 5 microfiches : negative.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drugs
General subdivision Inspection
Geographic subdivision United States.
Topical term or geographic name entry element Drugs
General subdivision Standards
Geographic subdivision United States.
Topical term or geographic name entry element Drug adulteration
General subdivision Government policy
Geographic subdivision United States.
Topical term or geographic name entry element Pharmaceutical industry
Geographic subdivision United States
General subdivision Quality control.
Topical term or geographic name entry element Product counterfeiting
Geographic subdivision United States.
776 08 -
Relationship information Online version:
Main entry heading United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.
Title Counterfeit bulk drugs
Record control number (OCoLC)852783298
Relationship information Print version:
Main entry heading United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.
Title Counterfeit bulk drugs
Record control number (OCoLC)503594555

No hay ítems disponibles.

logopucpr-y-vive

Contáctanos

¡Queremos saber de ti!

Tel. 787.841.2000 Ext. 1801

bibliotecavaldes@pucpr.edu

⁣Búscanos en las redes

© 2026 Desarrollado por Ignite Online • All Rights Reserved • Powered by Koha.